Austin Chih-Yu Chen

Person

San Marcos, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Bicyclic carboxamides and methods of use thereof
- Patent number 12,215,093
- Issue date Feb 4, 2025
- TEMPEST THERAPEUTICS, INC.
- Yalda Bravo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Muscarinic acetylcholine M1 receptor antagonists
- Patent number 12,054,487
- Issue date Aug 6, 2024
- Contineum Therapeutics, Inc.
- Thomas Schrader
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic carboxamides and methods of use thereof
- Patent number 11,795,156
- Issue date Oct 24, 2023
- TEMPEST THERAPEUTICS, INC.
- Yalda Bravo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Muscarinic acetylcholine M1 receptor antagonists
- Patent number 11,752,149
- Issue date Sep 12, 2023
- Pipeline Therapeutics, Inc.
- Yifeng Xiong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bicyclic compounds and their use in the treatment of cancer
- Patent number 11,738,009
- Issue date Aug 29, 2023
- TEMPEST THERAPEUTICS, INC.
- Yalda Bravo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Triazolone compounds and uses thereof
- Patent number 11,666,557
- Issue date Jun 6, 2023
- TEMPEST THERAPEUTICS, INC.
- Nicholas Simon Stock
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bicyclic compounds and their use in the treatment of cancer
- Patent number 11,638,704
- Issue date May 2, 2023
- TEMPEST THERAPEUTICS, INC.
- Yalda Bravo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Muscarinic acetylcholine M1 receptor antagonists
- Patent number 11,512,090
- Issue date Nov 29, 2022
- Pipeline Therapeutics, Inc.
- Yifeng Xiong
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic carboxamides and methods of use thereof
- Patent number 11,472,789
- Issue date Oct 18, 2022
- TEMPEST THERAPEUTICS, INC.
- Yalda Bravo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic carboxamides and methods of use thereof
- Patent number 11,440,897
- Issue date Sep 13, 2022
- TEMPEST THERAPEUTICS, INC.
- Yalda Bravo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic compounds and their use in the treatment of cancer
- Patent number 11,066,405
- Issue date Jul 20, 2021
- TEMPEST THERAPEUTICS, INC.
- Yalda Bravo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic carboxamides and methods of use thereof
- Patent number 10,968,201
- Issue date Apr 6, 2021
- TEMPEST THERAPEUTICS, INC.
- Yalda Bravo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aliphatic prolinamide derivatives
- Patent number 10,730,832
- Issue date Aug 4, 2020
- ORION OPHTHALMOLOGY LLC
- Austin Chih-Yu Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sulfide alkyl compounds for HBV treatment
- Patent number 10,710,959
- Issue date Jul 14, 2020
- Novira Therapeutics, Inc.
- Austin Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Triazolone compounds and uses thereof
- Patent number 10,568,871
- Issue date Feb 25, 2020
- TEMPEST THERAPEUTICS, INC.
- Nicholas Simon Stock
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaryl compounds as IRAK inhibitors and uses thereof
- Patent number 10,392,375
- Issue date Aug 27, 2019
- Merck Patent GmbH
- Catherine Jorand-Lebrun
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sulfide alkyl compounds for HBV treatment
- Patent number 10,196,351
- Issue date Feb 5, 2019
- Novira Therapeutics, Inc.
- Austin Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaryl compounds as IRAK inhibitors and uses thereof
- Patent number 10,059,701
- Issue date Aug 28, 2018
- Merck Patent GmbH
- Catherine Jorand-Lebrun
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaryl compounds as IRAK inhibitors and uses thereof
- Patent number 9,969,710
- Issue date May 15, 2018
- Merck Patent GmbH
- Catherine Jorand-Lebrun
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrazolone compounds and uses thereof
- Patent number 9,862,708
- Issue date Jan 9, 2018
- TEMPEST THERAPEUTICS, INC.
- Nicholas Simon Stock
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Triazolone compounds and uses thereof
- Patent number 9,776,976
- Issue date Oct 3, 2017
- Inception 2, Inc.
- Nicholas Simon Stock
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Triazolone compounds and uses thereof
- Patent number 9,676,754
- Issue date Jun 13, 2017
- Inception 2, Inc.
- Nicholas Simon Stock
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sulfide alkyl compounds for HBV treatment
- Patent number 9,597,332
- Issue date Mar 21, 2017
- Novira Therapeutics, Inc.
- Austin Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Triazolone compounds and uses thereof
- Patent number 9,505,728
- Issue date Nov 29, 2016
- Inception 2, Inc.
- Nicholas Simon Stock
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tricyclic compounds useful as neurogenic and neuroprotective agents
- Patent number 9,187,439
- Issue date Nov 17, 2015
- Inception Orion, Inc.
- Austin Chih-Yu Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
HCV NS3 protease inhibitors
- Patent number 8,987,195
- Issue date Mar 24, 2015
- Merck Sharp & Dohme Corp.
- Thomas Bara
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
LPAR1 ANTAGONISTS AND USES THEREOF
- Publication number 20250034110
- Publication date Jan 30, 2025
- Jeffrey Roger Roppe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MUSCARINIC ACETYLCHOLINE M1 RECEPTOR ANTAGONISTS
- Publication number 20250026758
- Publication date Jan 23, 2025
- Contineum Therapeutics, Inc.
- Thomas Schrader
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE COMPOUND OF MUSCARINIC ACETYLCHOLINE M1 RECEPTOR ANTAGO...
- Publication number 20240217981
- Publication date Jul 4, 2024
- Pipeline Therapeutics, Inc.
- Jeffrey Roppe
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BICYCLIC CARBOXAMIDES AND METHODS OF USE THEREOF
- Publication number 20240150316
- Publication date May 9, 2024
- Tempest Therapeutics, Inc.
- Yalda BRAVO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRIAZOLONE COMPOUNDS AND USES THEREOF
- Publication number 20240041837
- Publication date Feb 8, 2024
- Tempest Therapeutics, Inc.
- Nicholas Simon STOCK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MUSCARINIC ACETYLCHOLINE M1 RECEPTOR ANTAGONISTS
- Publication number 20230364082
- Publication date Nov 16, 2023
- Pipeline Therapeutics, Inc.
- Yifeng Xiong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MUSCARINIC ACETYLCHOLINE M1 RECEPTOR ANTAGONISTS
- Publication number 20230089921
- Publication date Mar 23, 2023
- Pipeline Therapeutics, Inc.
- Jill Melissa Baccei
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BICYCLIC CARBOXAMIDES AND METHODS OF USE THEREOF
- Publication number 20230045612
- Publication date Feb 9, 2023
- Tempest Therapeutics, Inc.
- Yalda BRAVO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MUSCARINIC ACETYLCHOLINE M1 RECEPTOR ANTAGONISTS
- Publication number 20220332721
- Publication date Oct 20, 2022
- Pipeline Therapeutics, Inc.
- Yifeng XIONG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BICYCLIC COMPOUNDS AND THEIR USE IN THE TREATMENT OF CANCER
- Publication number 20210387985
- Publication date Dec 16, 2021
- Tempest Therapeutics, Inc.
- Yalda BRAVO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AMINOAZINE AMIDES
- Publication number 20210363152
- Publication date Nov 25, 2021
- HOFFMANN-LA ROCHE INC.
- Jill Melissa Baccei
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MUSCARINIC ACETYLCHOLINE M1 RECEPTOR ANTAGONISTS
- Publication number 20210161889
- Publication date Jun 3, 2021
- Pipeline Therapeutics, Inc.
- Yifeng Xiong
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MUSCARINIC ACETYLCHOLINE M1 RECEPTOR ANTAGONISTS
- Publication number 20210155629
- Publication date May 27, 2021
- Pipeline Therapeutics, Inc.
- Thomas Schrader
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BICYCLIC CARBOXAMIDES AND METHODS OF USE THEREOF
- Publication number 20210024491
- Publication date Jan 28, 2021
- Tempest Therapeutics, Inc.
- Yalda BRAVO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BICYCLIC COMPOUNDS AND THEIR USE IN THE TREATMENT OF CANCER
- Publication number 20210008046
- Publication date Jan 14, 2021
- Tempest Therapeutics, Inc.
- Yalda BRAVO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BICYCLIC COMPOUNDS AND THEIR USE IN THE TREATMENT OF CANCER
- Publication number 20200283438
- Publication date Sep 10, 2020
- Tempest Therapeutics, Inc.
- Yalda BRAVO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRIAZOLONE COMPOUNDS AND USES THEREOF
- Publication number 20200138790
- Publication date May 7, 2020
- Tempest Therapeutics, Inc.
- Nicholas Simon STOCK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ALIPHATIC PROLINAMIDE DERIVATIVES
- Publication number 20190330146
- Publication date Oct 31, 2019
- Orion Ophthalmology LLC
- Austin Chih-Yu Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BICYCLIC CARBOXAMIDES AND METHODS OF USE THEREOF
- Publication number 20190315712
- Publication date Oct 17, 2019
- Tempest Therapeutics, Inc.
- Yalda BRAVO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SULFIDE ALKYL COMPOUNDS FOR HBV TREATMENT
- Publication number 20190202780
- Publication date Jul 4, 2019
- Novira Therapeutics, Inc.
- Austin Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROARYL COMPOUNDS AS IRAK INHIBITORS AND USES THEREOF
- Publication number 20180237426
- Publication date Aug 23, 2018
- Merck Patent GmbH
- Catherine JORAND-LEBRUN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROARYL COMPOUNDS AS IRAK INHIBITORS AND USES THEREOF
- Publication number 20180237413
- Publication date Aug 23, 2018
- Merck Patent GmbH
- Catherine JORAND-LEBRUN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRAZOLONE COMPOUNDS AND USES THEREOF
- Publication number 20180079745
- Publication date Mar 22, 2018
- Tempest Therapeutics, Inc.
- Nicholas Simon STOCK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SULFIDE ALKYL COMPOUNDS FOR HBV TREATMENT
- Publication number 20170298014
- Publication date Oct 19, 2017
- Novira Therapeutics, Inc.
- Austin Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRIAZOLONE COMPOUNDS AND USES THEREOF
- Publication number 20170239223
- Publication date Aug 24, 2017
- INCEPTION 2, INC.
- Nicholas Simon Stock
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRAZOLONE COMPOUNDS AND USES THEREOF
- Publication number 20170174666
- Publication date Jun 22, 2017
- INCEPTION 2, INC.
- Nicholas Simon Stock
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROARYL COMPOUNDS AS IRAK INHIBITORS AND USES THEREOF
- Publication number 20170081307
- Publication date Mar 23, 2017
- Merck Patent GmbH
- Catherine JORAND-LEBRUN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROARYL COMPOUNDS AS IRAK INHIBITORS AND USES THEREOF
- Publication number 20170081317
- Publication date Mar 23, 2017
- Merck Patent GmbH
- Catherine JORAND-LEBRUN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRIAZOLONE COMPOUNDS AND USES THEREOF
- Publication number 20160194292
- Publication date Jul 7, 2016
- INCEPTION 2, INC.
- Nicholas Simon Stock
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SULFIDE ALKYL COMPOUNDS FOR HBV TREATMENT
- Publication number 20160151375
- Publication date Jun 2, 2016
- Novira Therapeutics, Inc.
- Austin Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Austin Chih-Yu Chen

Person

Patents Grantslast 30 patents

Bicyclic carboxamides and methods of use thereof

Muscarinic acetylcholine M1 receptor antagonists

Bicyclic carboxamides and methods of use thereof

Muscarinic acetylcholine M1 receptor antagonists

Bicyclic compounds and their use in the treatment of cancer

Triazolone compounds and uses thereof

Bicyclic compounds and their use in the treatment of cancer

Muscarinic acetylcholine M1 receptor antagonists

Bicyclic carboxamides and methods of use thereof

Bicyclic carboxamides and methods of use thereof

Bicyclic compounds and their use in the treatment of cancer

Bicyclic carboxamides and methods of use thereof

Aliphatic prolinamide derivatives

Sulfide alkyl compounds for HBV treatment

Triazolone compounds and uses thereof

Heteroaryl compounds as IRAK inhibitors and uses thereof

Sulfide alkyl compounds for HBV treatment

Heteroaryl compounds as IRAK inhibitors and uses thereof

Heteroaryl compounds as IRAK inhibitors and uses thereof

Pyrazolone compounds and uses thereof

Triazolone compounds and uses thereof

Triazolone compounds and uses thereof

Sulfide alkyl compounds for HBV treatment

Triazolone compounds and uses thereof

Tricyclic compounds useful as neurogenic and neuroprotective agents

HCV NS3 protease inhibitors

Patents Applicationslast 30 patents

LPAR1 ANTAGONISTS AND USES THEREOF

MUSCARINIC ACETYLCHOLINE M1 RECEPTOR ANTAGONISTS

CRYSTALLINE COMPOUND OF MUSCARINIC ACETYLCHOLINE M1 RECEPTOR ANTAGO...

BICYCLIC CARBOXAMIDES AND METHODS OF USE THEREOF

TRIAZOLONE COMPOUNDS AND USES THEREOF

MUSCARINIC ACETYLCHOLINE M1 RECEPTOR ANTAGONISTS

MUSCARINIC ACETYLCHOLINE M1 RECEPTOR ANTAGONISTS

BICYCLIC CARBOXAMIDES AND METHODS OF USE THEREOF

MUSCARINIC ACETYLCHOLINE M1 RECEPTOR ANTAGONISTS

BICYCLIC COMPOUNDS AND THEIR USE IN THE TREATMENT OF CANCER

AMINOAZINE AMIDES

MUSCARINIC ACETYLCHOLINE M1 RECEPTOR ANTAGONISTS

MUSCARINIC ACETYLCHOLINE M1 RECEPTOR ANTAGONISTS

BICYCLIC CARBOXAMIDES AND METHODS OF USE THEREOF

BICYCLIC COMPOUNDS AND THEIR USE IN THE TREATMENT OF CANCER

BICYCLIC COMPOUNDS AND THEIR USE IN THE TREATMENT OF CANCER

TRIAZOLONE COMPOUNDS AND USES THEREOF

ALIPHATIC PROLINAMIDE DERIVATIVES

BICYCLIC CARBOXAMIDES AND METHODS OF USE THEREOF

SULFIDE ALKYL COMPOUNDS FOR HBV TREATMENT

HETEROARYL COMPOUNDS AS IRAK INHIBITORS AND USES THEREOF

HETEROARYL COMPOUNDS AS IRAK INHIBITORS AND USES THEREOF

PYRAZOLONE COMPOUNDS AND USES THEREOF

SULFIDE ALKYL COMPOUNDS FOR HBV TREATMENT

TRIAZOLONE COMPOUNDS AND USES THEREOF

PYRAZOLONE COMPOUNDS AND USES THEREOF

HETEROARYL COMPOUNDS AS IRAK INHIBITORS AND USES THEREOF

HETEROARYL COMPOUNDS AS IRAK INHIBITORS AND USES THEREOF

TRIAZOLONE COMPOUNDS AND USES THEREOF

SULFIDE ALKYL COMPOUNDS FOR HBV TREATMENT